organisms have re-emerged as the major hospital pathogens, which make the unmet medical needs for antibacterial therapy even worse. In searching for potent agents against Gram-positive pathogens, novel 7-(substituted)-aminomethyl-quinolone-3-carboxylic acids were designed, synthesized, and evaluated for their antibacterial activities in vitro. Many 7-monoarylaminomethyl derivatives exhibited high potency against
革兰氏阳性
生物已重新成为医院的主要病原体,这使得未得到满足的抗菌治疗的医疗需求更加严重。在寻找针对革兰氏阳性病原体的有效药物时,设计,合成了新型7-(取代)-
氨基甲基-
喹诺酮-3-
羧酸,并对其体外抗菌活性进行了评估。与参考药物:
万古霉素和
帕珠沙星相比,许多7-单芳基
氨基甲基衍
生物对革兰氏阳性
生物均显示出高效力。另外,一些7-单烷基
氨基甲基衍
生物对革兰氏阳性和革兰氏阴性
生物均表现出良好的活性。